临床T2N0期食管癌的治疗：综述
Management of clinical T2N0 esophageal cancer: a review.
作者信息
Vining Patrick, Birdas Thomas J
机构信息
Division of Cardiothoracic Surgery, Department of Surgery, Indiana University School of Medicine, Indianapolis, IN, USA.
出版信息
J Thorac Dis. 2019 Aug;11(Suppl 12):S1629-S1632. doi: 10.21037/jtd.2019.07.85.
Abstract
While management of locally advanced esophageal cancer has mostly involved multimodality therapy, management of clinical T2N0 patients has been more controversial, primarily as a result of inaccurate clinical staging with existing modalities. This review article examines current literature on this topic and provides recommendations for management of individual patients.
摘要
虽然局部晚期食管癌的治疗主要涉及多模式治疗，但临床T2N0患者的治疗一直存在更多争议，主要是由于现有模式的临床分期不准确。这篇综述文章研究了关于该主题的当前文献，并为个体患者的治疗提供了建议。
相似文献
1
Management of clinical T2N0 esophageal cancer: a review.临床T2N0期食管癌的治疗：综述
J Thorac Dis. 2019 Aug;11(Suppl 12):S1629-S1632. doi: 10.21037/jtd.2019.07.85.
2
Neoadjuvant therapy or upfront surgery? A systematic review and meta-analysis of T2N0 esophageal cancer treatment options.新辅助治疗还是 upfront 手术？T2N0 食管癌治疗选择的系统评价和荟萃分析。
Int J Surg. 2018 Jun;54(Pt A):176-181. doi: 10.1016/j.ijsu.2018.04.053. Epub 2018 May 3.
3
Management of T2 esophageal cancer.T2 期食管癌的治疗管理。
Surg Clin North Am. 2012 Oct;92(5):1169-78. doi: 10.1016/j.suc.2012.07.003. Epub 2012 Aug 11.
4
Controversies in the multimodality management of locally advanced esophageal cancer: evidence-based review of surgery alone and combined-modality therapy.局部晚期食管癌多模式治疗中的争议：单纯手术与综合治疗的循证综述
Ann Surg Oncol. 2004 Jul;11(7):665-73. doi: 10.1245/ASO.2004.10.026. Epub 2004 Jun 14.
5
[Is esophagectomy necessary for esophageal cancer patients with complete response after neoadjuvant chemoradiotherapy].新辅助放化疗后完全缓解的食管癌患者是否需要进行食管切除术
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Sep 25;21(9):983-986.
6
Predictors of Nodal Metastases for Clinical T2N0 Esophageal Adenocarcinoma.临床 T2N0 食管腺癌淋巴结转移的预测因素。
Ann Thorac Surg. 2018 Jul;106(1):172-177. doi: 10.1016/j.athoracsur.2018.02.087. Epub 2018 Apr 5.
7
Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.一项针对局部晚期食管肿瘤进行新辅助化疗后行食管切除术的II期试验的长期结果。
Ann Thorac Surg. 2008 Jun;85(6):1930-6; discussion 1936-7. doi: 10.1016/j.athoracsur.2008.01.097.
8
Neoadjuvant Therapy Vs Upfront Surgery for Clinical T2N0 Esophageal Cancer: A Systematic Review.新辅助治疗与 upfront 手术治疗 T2N0 期食管癌的临床疗效比较：一项系统评价。
Ann Thorac Surg. 2019 Sep;108(3):935-944. doi: 10.1016/j.athoracsur.2019.04.008. Epub 2019 May 8.
9
Curing patients with locally advanced esophageal cancer: an update on multimodality therapy.局部晚期食管癌患者的治疗：多模式治疗的最新进展
Dis Esophagus. 2006;19(6):448-53. doi: 10.1111/j.1442-2050.2006.00611.x.
10
Comparative effectiveness of upfront esophagectomy versus induction chemoradiation in clinical stage T2N0 esophageal cancer: A decision analysis.临床 T2N0 期食管癌直接手术与诱导放化疗的疗效比较：决策分析。
J Thorac Cardiovasc Surg. 2018 May;155(5):2221-2230.e1. doi: 10.1016/j.jtcvs.2018.01.006. Epub 2018 Jan 12.
引用本文的文献
1
Special requirements for TNM-staging in esophageal cancer.食管癌TNM分期的特殊要求。
J Thorac Dis. 2024 Jun 30;16(6):3535-3539. doi: 10.21037/jtd-23-1898. Epub 2024 May 30.
2
Metachronous Squamous Cell Carcinoma of the Esophagus After Resolution of Previous Adenocarcinoma.既往腺癌消退后发生的异时性食管鳞状细胞癌
ACG Case Rep J. 2023 Jul 8;10(7):e01097. doi: 10.14309/crj.0000000000001097. eCollection 2023 Jul.
3
Histological prognosticators in neoadjuvant naive oesophageal cancer patients.新辅助未治疗食管癌患者的组织学预后指标
Langenbecks Arch Surg. 2023 May 9;408(1):184. doi: 10.1007/s00423-023-02927-z.
4
Demographic, endoscopic and histological profile of esophageal cancer at the Gastroenterology Department of Maputo Central Hospital from January 2016 to December 2018.莫桑比克马普托中央医院消化内科 2016 年 1 月至 2018 年 12 月食管癌的人口统计学、内镜和组织学特征。
Pan Afr Med J. 2022 Feb 4;41:100. doi: 10.11604/pamj.2022.41.100.30941. eCollection 2022.
5
Staging esophageal cancer: low EUS accuracy in t2n0 patients.食管癌分期：EUS对T2N0患者的准确性较低。
Endosc Int Open. 2021 Mar;9(3):E313-E318. doi: 10.1055/a-1336-2505. Epub 2021 Feb 18.
本文引用的文献
1
Neoadjuvant Therapy Vs Upfront Surgery for Clinical T2N0 Esophageal Cancer: A Systematic Review.新辅助治疗与 upfront 手术治疗 T2N0 期食管癌的临床疗效比较：一项系统评价。
Ann Thorac Surg. 2019 Sep;108(3):935-944. doi: 10.1016/j.athoracsur.2019.04.008. Epub 2019 May 8.
2
Predictors of staging accuracy, pathologic nodal involvement, and overall survival for cT2N0 carcinoma of the esophagus.食管cT2N0期癌分期准确性、病理淋巴结受累及总生存的预测因素
J Thorac Cardiovasc Surg. 2019 Mar;157(3):1264-1272.e6. doi: 10.1016/j.jtcvs.2018.10.057. Epub 2018 Oct 19.
3
Accuracy of endoscopic ultrasound staging for T2N0 esophageal cancer: a National Cancer Database analysis.内镜超声对T2N0期食管癌分期的准确性：一项国家癌症数据库分析
J Gastrointest Oncol. 2018 Oct;9(5):887-893. doi: 10.21037/jgo.2018.01.16.
4
Does timing of esophagectomy following neoadjuvant chemoradiation affect outcomes? A meta-analysis.新辅助放化疗后行食管切除术的时机是否影响疗效？一项荟萃分析。
Int J Surg. 2018 Nov;59:11-18. doi: 10.1016/j.ijsu.2018.09.013. Epub 2018 Sep 24.
5
Neoadjuvant therapy or upfront surgery? A systematic review and meta-analysis of T2N0 esophageal cancer treatment options.新辅助治疗还是 upfront 手术？T2N0 食管癌治疗选择的系统评价和荟萃分析。
Int J Surg. 2018 Jun;54(Pt A):176-181. doi: 10.1016/j.ijsu.2018.04.053. Epub 2018 May 3.
6
Predictors of Nodal Metastases for Clinical T2N0 Esophageal Adenocarcinoma.临床 T2N0 食管腺癌淋巴结转移的预测因素。
Ann Thorac Surg. 2018 Jul;106(1):172-177. doi: 10.1016/j.athoracsur.2018.02.087. Epub 2018 Apr 5.
7
Role of neoadjuvant chemoradiotherapy in clinical T2N0M0 esophageal cancer: A population-based cohort study.新辅助放化疗在临床 T2N0M0 食管癌中的作用：基于人群的队列研究。
Eur J Surg Oncol. 2018 May;44(5):620-625. doi: 10.1016/j.ejso.2018.02.005. Epub 2018 Feb 13.
8
Comparative effectiveness of upfront esophagectomy versus induction chemoradiation in clinical stage T2N0 esophageal cancer: A decision analysis.临床 T2N0 期食管癌直接手术与诱导放化疗的疗效比较：决策分析。
J Thorac Cardiovasc Surg. 2018 May;155(5):2221-2230.e1. doi: 10.1016/j.jtcvs.2018.01.006. Epub 2018 Jan 12.
9
Exploring diagnostic and therapeutic implications of endoscopic mucosal resection in EUS-staged T2 esophageal adenocarcinoma.探讨超声内镜分期 T2 期食管腺癌内镜黏膜下切除的诊断和治疗意义。
Endoscopy. 2017 Oct;49(10):941-948. doi: 10.1055/s-0043-112492. Epub 2017 Jun 21.
10
Clinical T2N0 Esophageal Cancer: Identifying Pretreatment Characteristics Associated With Pathologic Upstaging and the Potential Role for Induction Therapy.临床T2N0期食管癌：识别与病理分期升级相关的治疗前特征及诱导治疗的潜在作用
Ann Thorac Surg. 2016 Jun;101(6):2102-11. doi: 10.1016/j.athoracsur.2016.01.033. Epub 2016 Apr 12.
Zotero 插件